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THE EMERGING EVIDENCE BASE FOR THERAPY FOR CHILDREN WITH  
LANGUAGE IMPAIRMENT, AND ITS IMPLICATIONS FOR LOGOPEDISTS
Elspeth McCartney
School of Psychological Sciences and Health, University of Strathclyde, Glasgow
This paper reflects on the current state of the evidence base relating to therapy interventions for language-impaired 
children. It accepts that logopedists should provide evidence for the effectiveness of their practices, and are eager 
to do so in order to enhance services for children. It reviews the ways that intervention effectiveness is measured, 
with some examples from personal research studies. It identifies two recent databases giving information relevant 
to logopedists: speechBITE™, and the ‘What Works’ data base that resulted from the Better Communication Re-
search Programme in England. The paper notes that, while the number of relevant studies is increasing, and posi-
tive effects of therapy are shown, there are few interventions as yet that show convincing evidence of effectiveness. 
The problem is largely that appropriate research studies have not been conducted, and such studies are not easy 
to undertake given small therapy services, the variety of children on individual therapists’ case loads, and a lack of 
research funding.
The paper concludes that a commitment to collect and evaluate evidence has been helpful to the development of 
logopedic professionals internationally, but that the current paucity of evidence on effective treatments may impact 
upon funders’ willingness to pay for logopedic services, affecting all practitioners. The need for closer integration 
between higher education institutions and clinical services in order to trial therapy approaches, and the overwhel-
ming need for research funding, are stressed. The importance of practising logopedists acting as researchers, 
collecting data and measuring outcomes, as exemplified by the case studies in this special edition of Logopedie, is 
also emphasised.
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Introduction
Professionals providing intervention for language im-
paired children have to answer the reasonable questi-
ons that arise from service users and service funders: 
‘Does what you are doing work? Do language impaired 
children benefit from therapy, and if so, by how much?’. 
These questions are also asked by logopedists about 
their own practice, as they aim to develop and improve 
the services they provide. Such questions lead to others 
about costs and efficiency, which are not addressed 
here. This paper aims to identify key issues in resear-
ching therapy. It briefly outlines the clinical model used 
for collecting and evaluating evidence of intervention 
effectiveness, with examples, then reports on two new 
and key sources that summarise how far the evidence-
base has developed for children with language impair-
ments: the SpeechBITE™ website, and the ‘What Works’ 
(2013) data base, developed following a recent research 
programme in England (the Better Communication Re-
search Programme: BCRP: c.f. Law et al. 2012). This 
programme amongst other important findings updated 
systematic reviews on intervention, and listed the evi-
dence for efficacy of widely-used language interventi-
ons on a searchable data-base.
Developing evidence
Procedures for evaluating evidence for interventions, in-
cluding therapy interventions, derive from medical mo-
dels. The aim is to develop interventions that are effective 
for specified types of children and that will ‘work’ when 
used by suitably qualified practitioners. Interventions 
must therefore be shown to be replicable and reliable, 
so that their procedures can be understood and used by 
many therapists, and if necessary can be explained to 
and used by others, such as parents, teachers and sup-
port staff. 
The framework used internationally for identifying levels 
of evidence, the quality of studies and the implementa-
tion cycle will briefly be reviewed, then current evidence 
for language impairment interventions will be related to 
this framework.
Levels of evidence
Interventions are ranked by the levels of evidence in-
herent in their study designs. The Centre for Evidence 
Based Medicine (2009) presents a refined hierarchy, but 
the six broad levels presented in Evidence Based Nursing 
Practice (no date) will be used in this discussion. 
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A series of randomised control trials (RCTs) identified by 
a comprehensive review of the literature (systematic re-
view) comprises Level One ‘best evidence’. RCTs rand-
omly allocate sufficiently large numbers of children to the 
intervention being trialled, and compare their progress 
with another intervention (the ‘counterfactual’ or control 
condition), often the current therapy programme on offer. 
Randomisation eliminates unintended child selection fac-
tors, and so results can reasonably be expected to trans-
fer to similar clients and contexts. If an intervention has 
received at least one full-scale RCT (Level Two evidence) 
it is possible to be fairly sure that results are not influen-
ced by unintended or undetected factors in the selection of 
children. An RCT also shows how much progress children 
would (probably) have made without the intervention, or if 
they had continued with their existing therapy (the coun-
terfactual comparison), through measuring the progress 
of children in the control condition. RCTs require a suf-
ficiently large number of children to show change; having 
children and their parents agree to inclusion in the trials 
(informed consent); randomising the children; delivering 
the planned amount of therapy (the prescribed ‘dosage’), 
and sticking closely to the pre-planned intervention (tre-
atment fidelity). A full-scale RCT for language-impaired 
school-aged children is described in detail in Boyle et al. 
(2007), and summarised in Boyle et al. (2009).
If an RCT shows evidence of effectiveness with these pro-
cedures in place, and if several such trials subsequently 
show very similar effects, it is possible to both assess the 
benefits attained by the intervention (effect sizes), and to 
be confident that the intervention will work when the the-
rapy is replicated in comparable contexts. 
RCTs are however expensive to conduct, and often requi-
re collaboration across many therapy services, and need 
to be staffed to deliver a sufficiently large amount of in-
tervention. For these reasons, many therapy studies use 
less expensive designs that do not use randomisation. 
These allow less certainty that their results would trans-
fer to other therapists and to other children. Level Three 
evidence is offered by studies that report on a complete 
group (cohort) of children, all of whom get the interven-
tion being evaluated, and that use reliable measures of 
language outcomes. Cohort studies provide no counter-
factual evidence to say how much change would have oc-
curred without therapy or with a different intervention. If 
however a cohort is well matched to a previous cohort of 
children whose outcomes are known, some comparisons 
can be made. An example of a cohort study with ‘histori-
cal control’ of this kind is McCartney et al. (2011).
Level Four evidence is from studies that are not experi-
mental, but where similar results are found by several re-
search centres. Individual case studies contribute to this 
evidence level, and case study series, where information 
on a number of clients is collected. Case studies provide 
examples of promising interventions and their outcomes, 
but offer no counterfactual evidence. However, a series 
of case studies with good outcomes offers grounds for 
further developing and evaluating an intervention. Indivi-
dual logopedists make significant contributions here, as 
evidenced in the papers in this special edition. 
Level Five evidence comprises consensus views from 
respected practitioners or committees of experts about 
what comprises good therapy, and Level Six the views 
of practitioners as to ‘what is currently done’. Levels 
Five and Six of course do not evidence efficacy, but col-
lect views from logopedists who presumably believe their 
practices are helpful, and are keen to share them with 
others. Professional position statements often include 
professional consensus views in their guidance on best 
practice (e.g. Communicating Quality 3: Royal College of 
Speech and Language Therapists (RCSLT) 2006).
In order to move evidence into practice, however, even an 
intervention with one or more RCTs demonstrating ef-
ficacy should be tried out in ‘real life’ conditions. Inter-
ventions that work in trials do not always prove effective 
in real-life situations. There can be many reasons for this 
– logopedists may not be able to apply the procedures, 
or for some reason children may not comply with them, 
or a family may not be able to attend throughout a leng-
thy intervention period. To establish real-world effective-
ness, an implementation trial is needed that determines 
the continued good outcomes of the intervention under 
real-life conditions (Medical Research Council 2008 p.8). 
No control is needed for an implementation trial, as it is 
the real-world use of the therapy, not its efficacy, which 
is being checked. Beyond this, there are studies of ef-
ficiency, i.e. the costs related to the benefits of the in-
tervention, which are not discussed here. The level of 
evidence and whether or not it has received a real-life 
implementation study determine the scientific commu-
nity’s perception of an intervention, and of course influ-
ences a therapy funder’s views of what interventions may 
be supported and paid for.
Evaluating interventions for language 
impairment
Practitioners need to assess the level of evidence for the 
interventions they want to use, and at times to access 
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the studies that provide this. Evaluating studies reporting 
on logopedic interventions has recently become simpler 
for professionals with the publication of the open-ac-
cess speechBITE™ (no date) database. This catalogues 
‘Best Interventions and Treatment Efficacy’ (BITE). The 
database lists systematic reviews (which are not rated) 
and rates clinical trials across the range of speech and 
language interventions for children and adults. It may 
be searched by clinical group, mode of intervention and 
target speech or language area. Trials are evaluated (by 
logopedists in Australia) using a reliable scoring system, 
Pedro-P – an amended version of the Physiotherapy Evi-
dence Database Rating (Pedro) scale (Murray et al. 2013). 
Randomised and non-randomised trials are rated, noting 
the presence or absence of key features of scientific qua-
lity, and giving a total score. The eleven features of high-
quality trials are that: 
1. Participant eligibility criteria are specified; 
2. Participants are randomly allocated to interventions. 
For cross-over studies, where participants all receive 
intervention(s) but at different times, participants are 
randomly allocated to the order in which treatments 
were received; 
3. Allocation is concealed from participants, i.e. they en-
ter the study without knowing to which intervention they 
will allocated, and the researchers do not influence the 
allocation;
4. The intervention groups are similar at baseline (first 
measures) regarding the most important prognostic in-
dicators;
5. There is ‘blinding’ of participants so that they do not 
know which arm of the trial they are in. This is not usually 
achieved in logopedic interventions, when children and 
their parents are aware of the therapy procedures under-
taken, and so know which intervention they are receiving;
6. There is ‘blinding’ of logopedists who administer the-
rapy as to which arm of the trial a participant is under-
taking. As for five above, this cannot usually happen in 
language therapy;
7. There is ‘blinding’ of assessors who measure at least 
one key intervention outcome, so that assessors do not 
know what intervention arm they children they assess 
have undertaken. This is an important feature in clinical 
research, as those who undertake therapy and then as-
sess their clients may unconsciously influence the mea-
surement of outcomes;
8. Measures of at least one key intervention outcome are 
obtained from more than 85% of the participants initially 
allocated to each group, so that participants lost to the 
trial do not overly affect the outcomes of the trial;
9. All participants for whom intervention outcome mea-
sures are available will have received the treatment or 
control condition as allocated. This should be available 
for at least one key outcome measure and preferably 
more; 
10. Between-intervention group statistical comparisons 
are reported for at least one key outcome;
11. The study provides both point measures (measures of 
the intervention effect) and measures of variability (e.g. 
standard deviations, confidence intervals) for at least one 
key outcome.
Adding the points which studies meet gives a total score, 
and this with consideration of which of the eleven fea-
tures were present or absent allows practitioners to 
make a rapid assessment of a trial’s quality, and helps 
in considering, evaluating and selecting therapies. The 
speechBITE™ database is expanding, and should conti-
nue to support the adoption of evidence-based practice.
Another key source for professionals about evidence 
for interventions published in English is the searchable 
What Works (2013) database. This is collated from a re-
view of interventions for speech, language and autistic 
spectrum disorders undertaken in England as part of the 
Better Communication Research Programme (Law et al. 
2012). The What Works (2013) database identifies widely-
used interventions, and rates them using a simplified 
three-point scale according to the level of evidence for 
their efficacy. Interventions are categorised as ‘Strong’ if 
at least one positive systematic review has been underta-
ken, with any subsequent trials. A ‘Moderate’ level inclu-
des a single RCT or a set of quasi-experimental studies, 
whereas an ‘Indicative’ level means that an intervention 
has good face validity but limited research evidence, such 
as only case studies or ‘before and after’ studies (Law 
et al. 2012, p. 12). By providing the level of evidence for 
interventions, the database gives the level of confidence 
with which they can be used. 
However, levels of evidence are not high. Thirty-eight in-
terventions for language impairment are listed, including 
those for non-specific language disorders and for prag-
matic communication but excluding those for speech 
disorders and stuttering. Of the thirty-eight, only two had 
strong evidence of efficacy, including one that had strong 
evidence against effecting change (FastForWord®). Of 
the remainder, half had moderate evidence (including 
one, Earobics, that did not show language change in 
children although it showed changes in phonological 
awareness), and the other half indicative levels only. 
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This is rather a worrying finding for the logopedist pro-
fession. The high profile of the Better Communication 
Research Programme in England, and the accessibility of 
the data base, means that the limited research evidence 
base for language interventions is showing rather publi-
cally. This will no doubt affect the decisions of therapy 
funders and commissioning bodies, perhaps especially 
in countries such as the UK where logopedists are part 
of national health services, and in others where health 
insurance funds interventions. 
Discussion
Accepting the need for a sound evidence base and adop-
ting the unifying scientific framework for evaluating in-
terventions has been helpful to the development of the 
logopedic profession internationally, and gives a sound 
footing for evaluating therapy interventions. But the cur-
rent paucity of evidence for effectiveness may impact 
upon funders’ willingness to pay for services, and under-
mine the confidence that practitioners and their clients 
place in the treatments offered. 
However, the fact that many interventions for language 
impaired children have not as yet shown efficacy does not 
mean that they are not efficacious – rather that they have 
not as yet been subjected to the rigorous trialling that 
would demonstrate their effects. This is due to factors 
such as small therapy services serving different types of 
client groups, variation amongst children on the case-
loads of individual therapists, making comparisons dif-
ficult and common interventions unlikely, and the variety 
of settings in which logopedists operate. There is also a 
lack of overall research policy in the field, and difficulties 
in transferring findings across language boundaries. 
However, a major factor is the lack of resources for clini-
cal research. Logopedic research is often competing for 
funds within larger medical or educational research pro-
grammes, and establishing the impact of language the-
rapy may not be deemed sufficiently important to fund in 
contest with interventions considered to be more crucial. 
Research is expensive, and logopedic research may sel-
dom reach priority status from funders. 
In the UK, as a step towards strengthening clinical re-
search, the Royal College of Speech and Language Thera-
pists is encouraging higher educational institutions who 
teach SLT students to form research ‘hubs’ with logope-
dists in their regions. This is a good idea, as universities 
have research expertise, and operating at a regional level 
could augment the numbers of relevant therapists and 
children eligible to enter trials, and provide an overar-
ching framework. But moving funding responsibilities to 
universities is also problematic – they also have to seek 
research resources, as co-ordinating practice-based re-
search in a systematic way can be very time-consuming. 
Nonetheless, such collaboration could fairly cheaply 
increase the number of repeat case studies and cohort 
studies available, with documented intervention proce-
dures and validated (ideally standardised) outcome mea-
sures, where therapists implement agreed interventions 
faithfully. With careful recording of the children who join 
each study and what happens to them, appropriate ethi-
cal approval, assessment of outcomes by those who do 
not deliver the therapy, and confidential uses of modern 
technology to facilitate cross-site communications, the 
evidence base could be considerably enhanced. 
Conclusions
The commitment to collect and evaluate evidence has 
been helpful to the development of the logopedic profes-
sion internationally, but the current lack of evidence on 
effective treatments is not satisfactory, and may impact 
upon funders’ willingness to pay for services. There is a 
need for all logopedists to become engaged in research, 
publishing case studies and the outcomes of interven-
tion, including outcomes showing limited or no progress. 
Closer integration between higher education institutions 
and clinical services would offer further opportunity to 
trial therapy approaches systematically. However, large-
scale randomised controlled trials are needed to move 
interventions upwards towards the ‘strong evidence’ ca-
tegory. Randomised trials require at least some (and of-
ten a lot!) of specific research funding. Logopedists now 
need to argue for appropriate research trial funding at 
all possible opportunities, and to engage alongside their 
professional bodies with policy makers in explaining how 
important this is.
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